Journey Medical (DERM) Enterprise Value: 2020-2025
Historic Enterprise Value for Journey Medical (DERM) over the last 4 years, with Sep 2025 value amounting to $148.6 million.
- Journey Medical's Enterprise Value rose 57.09% to $148.6 million in Q3 2025 from the same period last year, while for Sep 2025 it was $86.9 million, marking a year-over-year increase of 353.70%. This contributed to the annual value of $61.4 million for FY2024, which is 22.48% down from last year.
- According to the latest figures from Q3 2025, Journey Medical's Enterprise Value is $148.6 million, which was up 1.13% from $147.0 million recorded in Q2 2025.
- Over the past 5 years, Journey Medical's Enterprise Value peaked at $148.6 million during Q3 2025, and registered a low of -$21.7 million during Q3 2021.
- Its 3-year average for Enterprise Value is $74.9 million, with a median of $79.2 million in 2023.
- In the last 5 years, Journey Medical's Enterprise Value slumped by 459.14% in 2021 and then skyrocketed by 3,879.77% in 2023.
- Over the past 5 years, Journey Medical's Enterprise Value (Quarterly) stood at $40.5 million in 2021, then plummeted by 95.09% to $2.0 million in 2022, then soared by 3,879.77% to $79.2 million in 2023, then dropped by 22.48% to $61.4 million in 2024, then surged by 57.09% to $148.6 million in 2025.
- Its Enterprise Value stands at $148.6 million for Q3 2025, versus $147.0 million for Q2 2025 and $115.2 million for Q1 2025.